These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35863363)

  • 1. What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies.
    Jacobs TG; Schouwenburg S; Penazzato M; Archary M; Ruel TD; van den Anker J; Burger DM; Cressey TR; Abrams EJ; Lyall H; Bekker A; Colbers A; ;
    Lancet HIV; 2022 Sep; 9(9):e649-e657. PubMed ID: 35863363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.
    Clarke DF; Penazzato M; Capparelli E; Cressey TR; Siberry G; Sugandhi N; Mirochnick M;
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):83-93. PubMed ID: 29039686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M; Best BM; Clarke DF
    Clin Perinatol; 2010 Dec; 37(4):907-27, xi. PubMed ID: 21078458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to accelerating the study of new antiretrovirals in pregnancy.
    Abrams EJ; Calmy A; Fairlie L; Mahaka IC; Chimula L; Flynn PM; Kinuthia J; Myer L; Khoo SH; Musoke P; Zwerski S; Zech JM; Lockman S; Siberry GK
    J Int AIDS Soc; 2022 Jul; 25 Suppl 2(Suppl 2):e25916. PubMed ID: 35851757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.
    Bekker A; Capparelli EV; Violari A; Cotton MF; Cababasay M; Wang J; Mathiba R; Wiesner L; Wiznia A; Samson P; Browning R; Moye J; Nakwa FL; Decloedt E; Rabie H; Mirochnick M; Cressey TR;
    Lancet HIV; 2022 Jan; 9(1):e24-e31. PubMed ID: 34883066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 8. Advancing the prevention and treatment of HIV in children: priorities for research and development.
    Penazzato M; Townsend CL; Sam-Agudu NA; Ruel TD; Archary M; Bekker A; Cressey TR; Colbers A; Sugandhi N; Rojo P; Rakhmanina N; Watkins M; Frigati L; Mukui I; Hafiz A; Vicari M; Capparelli EV; Abrams EJ;
    Lancet HIV; 2022 Sep; 9(9):e658-e666. PubMed ID: 35863362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV.
    Rojo P; Carpenter D; Venter F; Turkova A; Penazzato M
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25576. PubMed ID: 32869500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral Drug Recommendations for HIV Treatment and Prevention.
    Shalev N; Brudney KF; Scherer ML
    JAMA; 2021 Mar; 325(9):888-889. PubMed ID: 33651085
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral Drug Recommendations for HIV Treatment and Prevention-Reply.
    Saag MS; Gandhi RT; Sax PE
    JAMA; 2021 Mar; 325(9):889-890. PubMed ID: 33651088
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy.
    Brooks KM; Scarsi KK; Mirochnick M
    Obstet Gynecol Clin North Am; 2023 Mar; 50(1):205-218. PubMed ID: 36822704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A call to accelerate antiretroviral development for neonates.
    Gaur AH; Siberry GK
    Lancet HIV; 2024 Feb; 11(2):e65-e67. PubMed ID: 38296361
    [No Abstract]   [Full Text] [Related]  

  • 18. Highly active antiretroviral therapy in neonates and young infants.
    Bell GS
    Neonatal Netw; 2004; 23(2):55-64. PubMed ID: 15077862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Antiretroviral Therapeutic Strategies for HIV.
    Cunha RF; Simões S; Carvalheiro M; Pereira JMA; Costa Q; Ascenso A
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.